BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Africa/Nairobi
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0300
TZNAME:EAT
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230221T080000
DTEND;TZID=America/New_York:20230222T170000
DTSTAMP:20260404T013146
CREATED:20221213T181639Z
LAST-MODIFIED:20221213T181639Z
UID:7093-1676966400-1677085200@carb-x.org
SUMMARY:2023 UNIVERSAL HEALTH COVERAGE (UHC) IN AN ERA OF ANTIMICROBIAL RESISTANCE (AMR) AND PANDEMICS CONFERENCE
DESCRIPTION:Built upon the outcomes of the 2018 High-level Meeting spearheaded by ASEF\, the high-level conference on “Universal Health Coverage (UHC) in an Era of Antimicrobial Resistance (AMR) and Pandemics” is co-organised by Asia-Europe Foundation (ASEF)\, AMR Clinical Reference Center and the Ministry of Foreign Affairs of Japan. The conference will take place on 21-22 February 2023 in Tokyo\, Japan.   \nThe overall aim of this conference is to facilitate a much-needed dialogue between governments and other stakeholders on practical ways to integrate a concern for AMR into UHC. Unlike short-term measures and funding schemes\, health systems are here to stay. Accordingly\, the conference will discuss sustainable actions on AMR using the health system approach. Actionable AMR strategies that address the need to support high quality science and provide incentives to develop and produce new antimicrobials will also be considered. The conference will explore the links between mitigating AMR under UHC and pandemic preparedness. Last but not least\, possible international collaborations and effective coordination mechanisms will also be sought\, as AMR cannot be solved by a single country on its own.  \nThe conference will bring together senior-level health officials who are working in the areas of UHC\, AMR\, and Pandemic Preparedness and Response (PPR). The conference will feature presentations and panel discussions on topical subjects\, such as about innovative ideas on R&D and commercialisation of antimicrobials for sustainability\, as well as group discussions on priorities for international cooperation between Asia and Europe to support progress towards sustainable UHC while containing risks of emerging infectious diseases\, including AMR.  \nTo learn more about the conference background\, its audience\, partners\, and other details\, please click here. \nThis high-level conference is an invitation-only event. 
URL:https://carb-x.org/event/2023-universal-health-coverage-uhc-in-an-era-of-antimicrobial-resistance-amr-and-pandemics-conference/
LOCATION:Tokyo Station Hotel
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20230202T150000
DTEND;TZID=Europe/Berlin:20230202T170000
DTSTAMP:20260404T013146
CREATED:20221223T163438Z
LAST-MODIFIED:20221223T163438Z
UID:7162-1675350000-1675357200@carb-x.org
SUMMARY:Clinical Workshop on Small Molecules and Biologicals
DESCRIPTION:The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals\, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one\, therefore knowledge of the first part or other workshops of this series is not required. \n  \nThe workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies\, ethics committee\, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct. \n  \nThe workshop will be held as a weekly webinar over the course of three weeks with the following topics: \n\nSession 1: Introduction on clinical development\nThursday 19th January 2023\, start at 3 pm (CET)\nSession 2: Role of ethics committee and supporting infrastructures\nThursday 26th January 2023\, start at 3 pm (CET)\nSession 3: Regulatory background of clinical studies\nThursday 2nd February 2023\, start at 3 pm (CET)\n\n  \nFor further information\, please see the agenda attached. \n  \nFor registration\, please contact OSRA@PEI.de until 12th  of January 2023 including if you are affiliated with DZIF or CARB-X.
URL:https://carb-x.org/event/clinical-workshop-on-small-molecules-and-biologicals-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230201T080000
DTEND;TZID=America/New_York:20230202T170000
DTSTAMP:20260404T013146
CREATED:20221214T151039Z
LAST-MODIFIED:20221214T151039Z
UID:7101-1675238400-1675357200@carb-x.org
SUMMARY:ANTIMICROBIAL CHEMOTHERAPY CONFERENCE (ACC 2023)
DESCRIPTION:This virtual conference is jointly organised by BSAC and GARDP.  For ACC2023\, the collaborating organisations are Africa CDC and ReAct Africa.
URL:https://carb-x.org/event/antimicrobial-chemotherapy-conference-acc-2023/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20230126T150000
DTEND;TZID=Europe/Berlin:20230126T170000
DTSTAMP:20260404T013146
CREATED:20221223T163355Z
LAST-MODIFIED:20221223T163355Z
UID:7160-1674745200-1674752400@carb-x.org
SUMMARY:Clinical Workshop on Small Molecules and Biologicals
DESCRIPTION:The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals\, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one\, therefore knowledge of the first part or other workshops of this series is not required. \n  \nThe workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies\, ethics committee\, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct. \n  \nThe workshop will be held as a weekly webinar over the course of three weeks with the following topics: \n\nSession 1: Introduction on clinical development\nThursday 19th January 2023\, start at 3 pm (CET)\nSession 2: Role of ethics committee and supporting infrastructures\nThursday 26th January 2023\, start at 3 pm (CET)\nSession 3: Regulatory background of clinical studies\nThursday 2nd February 2023\, start at 3 pm (CET)\n\n  \nFor further information\, please see the agenda attached. \n  \nFor registration\, please contact OSRA@PEI.de until 12th  of January 2023 including if you are affiliated with DZIF or CARB-X.
URL:https://carb-x.org/event/clinical-workshop-on-small-molecules-and-biologicals-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230120T190000
DTEND;TZID=America/New_York:20230120T200000
DTSTAMP:20260404T013146
CREATED:20221223T153345Z
LAST-MODIFIED:20221223T153604Z
UID:7150-1674241200-1674244800@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #2
DESCRIPTION:Register here for the 2nd of 2 Q&A sessions on the upcoming CARB-X funding rounds
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20230119T150000
DTEND;TZID=Europe/Berlin:20230119T170000
DTSTAMP:20260404T013146
CREATED:20221223T163310Z
LAST-MODIFIED:20221223T163310Z
UID:7158-1674140400-1674147600@carb-x.org
SUMMARY:Clinical Workshop on Small Molecules and Biologicals
DESCRIPTION:The DZIF Product Development Unit (PDU) invites you to the second part of our Clinical Workshop on Small Molecules and Biologicals\, which will take place in January and February 2023 as an online format. This second part of the workshop is independent from the first one\, therefore knowledge of the first part or other workshops of this series is not required. \n  \nThe workshop will cover different aspects of clinical trial design and the application process. Experts from regulatory bodies\, ethics committee\, industry and supporting infrastructures as well as DZIF scientists will provide relevant guidance and share their experience in clinical trial planning and conduct. \n  \nThe workshop will be held as a weekly webinar over the course of three weeks with the following topics: \n\nSession 1: Introduction on clinical development\nThursday 19th January 2023\, start at 3 pm (CET)\nSession 2: Role of ethics committee and supporting infrastructures\nThursday 26th January 2023\, start at 3 pm (CET)\nSession 3: Regulatory background of clinical studies\nThursday 2nd February 2023\, start at 3 pm (CET)\n\n  \nFor further information\, please see the agenda attached. \n  \nFor registration\, please contact OSRA@PEI.de until 12th  of January 2023 including if you are affiliated with DZIF or CARB-X.
URL:https://carb-x.org/event/clinical-workshop-on-small-molecules-and-biologicals/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230119T080000
DTEND;TZID=America/New_York:20230119T090000
DTSTAMP:20260404T013146
CREATED:20221223T153126Z
LAST-MODIFIED:20221223T153126Z
UID:7148-1674115200-1674118800@carb-x.org
SUMMARY:CARB-X Funding Rounds Q&A #1
DESCRIPTION:Register for the 1st of 2 Q&A sessions on the upcoming CARB-X funding rounds: Webinar Registration – Zoom
URL:https://carb-x.org/event/carb-x-funding-rounds-qa-1/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221213T080000
DTEND;TZID=America/New_York:20221213T170000
DTSTAMP:20260404T013146
CREATED:20220722T204701Z
LAST-MODIFIED:20220722T204701Z
UID:6485-1670918400-1670950800@carb-x.org
SUMMARY:Infection 2022: BSAC Winter Conference\, Nouveau Frontiers in Infection: This time its personal!
DESCRIPTION:
URL:https://carb-x.org/event/infection-2022-bsac-winter-conference-nouveau-frontiers-in-infection-this-time-its-personal/
LOCATION:Royal College of Physicians\, London
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221206T080000
DTEND;TZID=America/New_York:20221206T170000
DTSTAMP:20260404T013146
CREATED:20221128T203638Z
LAST-MODIFIED:20221128T203638Z
UID:7053-1670313600-1670346000@carb-x.org
SUMMARY:MassBio Innovation Week
DESCRIPTION:Join us for our first ever Innovation Week! Each day of Innovation Week we will showcase emerging companies or academic research that could have a transformational impact on all patients. Our goal is to use our global platform to connect these changemakers to an audience of prospective partners\, investors\, stakeholders\, and other ecosystem leaders that can help them take the next step with their science. \nIf you are a founder or researcher who is interested in being featured and are working in the oncology\, infectious disease\, cardiovascular and metabolic disease\, rare disease\, or neuroscience therapeutic areas\, we encourage you to apply to be a featured participant. \nSpecifically\, we plan to highlight founders and researchers: \n\nFrom traditionally under-represented backgrounds in the industry – including people of color\, women\, the LGBTQIA+ community\, and people with disabilities\nWho are working towards greater health equity\, clinical diversity\, and/or who are making an impact in underserved disease areas or diseases that adversely affect underrepresented communities\n\nWe will feature just five companies or researchers each day of the week (Monday\, Dec 5\, 2022: Oncology\, Tuesday\, Dec 6 2022: Infectious Diseases (specifically\, AMR)\, Wednesday\, Dec 7\, 2022: Cardiovascular and metabolic diseases and Rare Diseases\, Thursday\, Dec 8\, 2022: Neuroscience). Each founder will have 20 minutes to present\, with 5 minutes of audience Q&A following their presentation; presentations will happen live and via Zoom webinar each afternoon EST. \n  \nFeatured speakers include Dr. Erin Duffy\, Chief of Research & Development of CARB-X
URL:https://carb-x.org/event/massbio-innovation-week/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221124T080000
DTEND;TZID=America/New_York:20221125T170000
DTSTAMP:20260404T013146
CREATED:20221101T210717Z
LAST-MODIFIED:20221101T210717Z
UID:6949-1669276800-1669395600@carb-x.org
SUMMARY:3rd Global High-Level Ministerial Conference on AMR
DESCRIPTION:The Sultanate of Oman is hosting the 3rd High-level Ministerial Conference on Antimicrobial Resistance (AMR) in Muscat\, Oman on 24 and 25 November 2022 to accelerate tackling AMR at the national\, regional\, and global levels and to enhance international cooperation. It will build on the success of the two previous High-level Ministerial Conferences held in the Netherlands in 2014 and 2019. High-level participation will include ministers of health\, agriculture\, animal health\, the environment\, and finance\, as well as policymakers\, key global experts\, and representatives from the private sector\, civil society\, research institutions\, and multilateral organizations. The conference will be conducted through keynote speeches\, case studies to demonstrate best practices\, and interactive discussions between participants. The conference will be an opportunity for an interactive dialogue on One Health action to address the AMR pandemic. \nThe Third Global High-level Ministerial Conference on Antimicrobial Resistance will center on the theme of paving the way to bold and specific political commitments in the United Nations General Assembly High Level Meeting on AMR (UNGA HLM) in 2024. It is the intention of the Government of Oman that the expected outcomes of the Conference\, including the content of the Manifesto\, will inform the upcoming UNGA HLM in 2024.
URL:https://carb-x.org/event/3rd-global-high-level-ministerial-conference-on-amr/
LOCATION:Muscat\, Sultanate of Oman
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221115T080000
DTEND;TZID=America/New_York:20221116T170000
DTSTAMP:20260404T013146
CREATED:20221101T210516Z
LAST-MODIFIED:20221101T210516Z
UID:6947-1668499200-1668618000@carb-x.org
SUMMARY:9th Nikkei FT Communicable Diseases Conference
DESCRIPTION:The outbreak of COVID-19 has not only revealed Japan’s lag in such areas including R&D of domestic vaccines and medicines\, digitalization of its medical systems\, and crisis management system itself\, but also revealed the vulnerability in the global health system. Developing countries are also confronted with infection controls\, which results in virus mutation and spread malaria\, tuberculosis\, and many other emerging and re-emerging communicable diseases. \nNikkei Inc. has been organizing the annual Nikkei FT Communicable Diseases Conference since 2014\, gathering internationally renowned experts in the field; representatives of the private sector\, academia and high-ranking government officials responsible for health\, both within and outside Japan. \nThe 9th Conference is to be held on 15th -16th November\, discussing how the global health communities should fight against communicable diseases\, and how Japan can maximize its contribution. Through Nikkei group’s diverse media network\, the concrete and practical action plans that had been proposed from the conference will be disseminated globally.
URL:https://carb-x.org/event/9th-nikkei-ft-communicable-diseases-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221115T080000
DTEND;TZID=America/New_York:20221116T170000
DTSTAMP:20260404T013146
CREATED:20220722T204522Z
LAST-MODIFIED:20220831T155348Z
UID:6482-1668499200-1668618000@carb-x.org
SUMMARY:BARDA Industry Day 2022
DESCRIPTION:The Biomedical Advanced Research and Development Authority (BARDA)\, a component of the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR)\, invites you to participate in our annual conference to learn about U.S. Government medical countermeasure priorities\, interact with the BARDA and ASPR teams\, and network with public and private sector colleagues. \nFor more information regarding the above offices\, and their missions\, please visit the following links: BARDA\, ASPR\, and HHS. \nThis year’s lineup will have an assortment of BARDA program briefings\, featured speakers\, special sessions\, and breakout sessions addressing our efforts towards our four strategic goals of enhancing preparedness\, response\, and partnerships against future threats. There will be a renewed focus on strengthening connections\, networking\, and collaboration within our virtual event environment. \nStay in the loop for BID 2022 announcements and details by following BARDA on Twitter\, LinkedIn and Instagram and visiting our website. \nWe look forward to seeing you online on November 15-16\, 2022!
URL:https://carb-x.org/event/barda-industry-day-2022/
LOCATION:Virtual
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221107T080000
DTEND;TZID=America/New_York:20221209T170000
DTSTAMP:20260404T013146
CREATED:20221103T174439Z
LAST-MODIFIED:20221103T191507Z
UID:6972-1667808000-1670605200@carb-x.org
SUMMARY:Fundamentals of in vitro diagnostic product development: Making the move from academic and entrepreneurial R&D to product development webinar series
DESCRIPTION:Are you an India-based academic\, R&D manager or scientist interested in transitioning your #AMR #bacterial #diagnostic into an IVD product? \n🖥️ Register for the 5-part seminar series from November 7 through December 9. \nTopics include: \n*️ (11 Nov.) Product development process \n*️ (18 Nov.) Design controls \n*️ (21 Nov.) Real-life stories: Academia to commercialization \n*️ (2 Dec.) Quality management and good laboratory practices \n*️ (9 Dec.) Case study: Why the fundamentals matter \nQ&A Panelists: \n*️ Taslimarif Saiyed\, Director and CEO\, C-CAMP\n*️ Rangarajan Sampath\, Senior Vice President and Head\, Center for Innovation in Diagnostics\, Siemens Healthineers\n*️ Tara deBoer\, Chief Executive Officer\, BioAmp Diagnostics\n*️ Debkishore Mitra\, Chief Technology Officer and co-founder\, Lucira Health\n*️ Chandrasekhar Nair\, Director\, Molbio Diagnostics\n*️ Peter J. Dailey\, Senior Technical Officer\, FIND \nModerated by Betsy Wonderly Trainor\, Diagnostics Alliance Director\, CARB-X \n47% of the global population does not have access to basic diagnostics. To increase access where the global AMR burden is most acute (see fig. 2)\, CARB-X is partnering with FIND and C-CAMP to support the diagnostic product development ecosystem in India.
URL:https://carb-x.org/event/fundamentals-of-in-vitro-diagnostic-product-development-making-the-move-from-academic-and-entrepreneurial-rd-to-product-development-webinar-series/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221025
DTEND;VALUE=DATE:20221029
DTSTAMP:20260404T013146
CREATED:20201203T003052Z
LAST-MODIFIED:20210309T185342Z
UID:4680-1666656000-1667001599@carb-x.org
SUMMARY:2022 Drug Discovery & Development Centre (H3D) Symposium: Celebrating a Decade of Infectious Diseases Drug Discovery and Development in Africa
DESCRIPTION:COVID Update: We are less than 8 weeks away from the H3D 2021 Symposium which was scheduled for 10th – 12th March 2021. Unfortunately\, I regret to announce that our organizing committee has decided to cancel the H3D 2021 Symposium\, which was in fact a rescheduled version of the original H3D 2020 symposium. As all of us are aware\, the COVID-19 outbreak continues to pose serious transmission risks for all face-to-face interactions\, particularly with large international events like this symposium. In addition to the transmission risk\, navigating changing regulations with regards to international travel and gatherings is quite daunting to all. Given the risks and uncertainty\, I hope that you will understand the reasoning for the cancellation. \nHowever\, I am pleased to inform you that we will be hosting a new H3D symposium from 25th-28th Oct 2022 at the same venue\, Spier Wine Estate in Stellenbosch outside of Cape Town\, South Africa. We hope you will consider joining us then. \nWelcome from Kelly Chibale\, Chair of the 2020 H3D Symposium Committee:\nI would like to extend an invitation to you to attend the 2021 Symposium hosted by the Drug Discovery & Development Centre (H3D). This will be the 4th H3D Symposium to be held in Africa (the 3rd in the Western Cape) and is a very special Symposium as it marks the 10th anniversary of the launch of H3D. Thus\, the theme of this special H3D symposium was derived as ‘Celebrating a Decade of Infectious Diseases Drug Discovery and Development’. The Symposium will cover the Centre’s research over 10 years conducted on Malaria\, Tuberculosis (TB)\, Neglected Tropical Diseases (NTDs) and drug resistant infections of bacterial origin towards combating AntiMicrobial Resistance (AMR). \nThe Symposium takes place in true Cape style at the Spier Hotel\, surrounded by leafy vineyards and beautiful mountain scenery and situated on the outskirts of the historic and picturesque old town of Stellenbosch. The organizing committee is currently encouraging participation in the symposium by drug discovery scientists from Africa\, as well from all over the globe\, who are working on the discovery of drugs to combat TB\, Malaria\, AMR and a host of NTDs. Through this symposium\, we aim to ensure that all these highly infectious\, deleterious diseases that primarily affect the African population\, will receive worldwide attention in both scientific and non-scientific arenas. \nI urge you to consider participating and making the most of this opportunity. Besides networking with the other delegates\, there will be wonderful scenery to admire and activities to enjoy. I hope that participation in this symposium will inspire your further research for the next decade! \nCARB-X participants include Erin Duffy\, Chief of R&D. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/2020-drug-discovery-development-centre-h3d-symposium-celebrating-a-decade-of-infectious-diseases-drug-discovery-and-development-in-africa/
LOCATION:Spier Hotel and Conference Centre\, Stellenbosch\, South Africa
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221019T080000
DTEND;TZID=America/New_York:20221023T170000
DTSTAMP:20260404T013146
CREATED:20220722T204411Z
LAST-MODIFIED:20220722T204411Z
UID:6479-1666166400-1666544400@carb-x.org
SUMMARY:Infectious Diseases Week 2022
DESCRIPTION:ID Week Learning Objectives: \nUpdate infectious diseases clinicians\, investigators\, infection preventionists\, and pharmacists with state of- the-art developments in the field\, including timely reviews of recent advances in clinical care and research\, and original reports of clinical\, translational\, and basic research in infectious diseases and healthcare epidemiology. \nBridge the widening gaps among the fields of infectious diseases clinical practice and research\, including clinical\, epidemiological\, health services\, implementation\, translational and basic research. \nPromote multi-disciplinary dialogue and collaboration among clinicians\, investigators and pharmacists\, thus facilitating advances in the prevention\, diagnosis and treatment of infectious diseases. \nProvide training in skills that promote the Infectious Disease specialty\, including medical education\, leadership and advocacy for policies that impact infectious diseases practice and the healthcare team.
URL:https://carb-x.org/event/infectious-diseases-week-2022/
LOCATION:London\, UK
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221016T080000
DTEND;TZID=America/New_York:20221018T170000
DTSTAMP:20260404T013146
CREATED:20220722T204059Z
LAST-MODIFIED:20220722T204059Z
UID:6477-1665907200-1666112400@carb-x.org
SUMMARY:World Health Summit 2022
DESCRIPTION:3 DAYS – 100+ NATIONS – 400+ SPEAKERS – 6\,000+ PARTICIPANTS \nHEALTH FOR ALL IS THE GOAL – WHS 2022 IS THE EVENT\n#WHS2022 – where science\, politics\, the private sector and civil society meet for inspiring talks\, enhanced cooperations and new solutions.\n  \nThe World Health Summit strengthens exchange\, stimulates innovative solutions to health challenges\, fosters global health as a key political issue and promotes the global health debate in the spirit of the UN Sustainable Development Goals: SDG 17 “Partnership for the Goals”. \nWHS 2022 will focus on “Making the Choice for Health” by reflecting on the most pressing topics\, including: \n\nInvestment for Health and Well-Being\nClimate Change and Planetary Health\nArchitecture for Pandemic Preparedness\nDigital Transformation for Health\nFood Systems and Health\nHealth Systems Resilience and Equity\nGlobal Health for Peace\n\n\nRead more about the first joint World Health Summit with WHO
URL:https://carb-x.org/event/world-health-summit-2022/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221015T080000
DTEND;TZID=America/New_York:20221023T170000
DTSTAMP:20260404T013146
CREATED:20220722T203837Z
LAST-MODIFIED:20220722T203837Z
UID:6474-1665820800-1666544400@carb-x.org
SUMMARY:Interdisciplinary Course on Antibiotics and Resistance ICARe
DESCRIPTION:The emergence and spread of bacteria resistant to many drug classes seriously threaten all branches of modern medicine. There is currently no course providing advanced instruction on antibiotics and resistance. The specific goal of ICARe is to bring leaders in academics and industry together with trained scientists at the dawn of their careers. Cutting-edge approaches for the study of resistance and antibiotic discovery will be examined.
URL:https://carb-x.org/event/interdisciplinary-course-on-antibiotics-and-resistance-icare/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221013T080000
DTEND;TZID=America/New_York:20221014T170000
DTSTAMP:20260404T013146
CREATED:20221011T193720Z
LAST-MODIFIED:20221011T193720Z
UID:6845-1665648000-1665766800@carb-x.org
SUMMARY:Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance - A Workshop
DESCRIPTION:On October 13-14\, 2022\, the Forum on Drug Discovery\, Development\, and Translation\, the Forum on Medical and Public Health Preparedness for Disasters and Emergencies\, and the Forum on Microbial Threats will host a public workshop for stakeholders to discuss the current landscape of rapid point-of-care diagnostics to address antibiotic resistance\, consider challenges and opportunities for spurring innovation\, and discuss practical next steps for accelerating the development of new diagnostic tools. \nBackground\nThe use and misuse of antibiotics contributes to the rise in drug-resistant bacteria – a serious and worsening threat to human health. Addressing the problem of antibiotic resistance requires measures to spur innovation and ensure the prudent use of existing drugs. Rapid point-of-care diagnostics can play an important role in avoiding unnecessary use of antimicrobials by providing clinicians with the right information at the right time to help them make decisions about appropriate drug treatment for patients. Diagnostics also have the capacity to support early detection and diagnosis of drug-resistant bacterial infections\, enable disease surveillance\, and help prevent disease spread. \nThe public workshop will feature invited presentations and discussions to: \n\nExamine the current state of rapid diagnostic development\, including examples of successes and limitations of current approaches.\nConsider the unique challenges for the development and use/uptake of rapid diagnostics in health care settings (e.g.\, feasibility of clinical utility studies)\nConsider gaps that rapid diagnostics may be best-suited to address (e.g. tools to support targeted treatment decisions in the healthcare setting\, tools to enable real-time surveillance based on routine hospital data).\nDiscuss practical short- and long-term opportunities for spurring the development of new diagnostics that can help address antibiotic resistance.\n\nPlanning Committee\nKent E. Kester (co-chair)\, International AIDS Vaccine Initiative \nBetsy Wonderly Trainor (co-chair)\, CARB-X \nJohn Billington\, GSK \nCarey-Ann Burnham\, Washington University School of Medicine in St. Louis \nPaul Eder\, National Institute of Allergy and Infectious Diseases\, NIH \nDeborah Hung\, Harvard Medical School \nAmanda Jezek\, Infectious Diseases Society of America \nRobin Patel\, Mayo Clinic \nRibhi Shawar\, Center for Devices and Radiological Health\, FDA \nSusan Van Meter\, The American Clinical Laboratory Association
URL:https://carb-x.org/event/accelerating-the-development-and-uptake-of-rapid-diagnostics-to-address-antibiotic-resistance-a-workshop/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20221012T090000
DTEND;TZID=Europe/London:20221012T170000
DTSTAMP:20260404T013146
CREATED:20220823T135256Z
LAST-MODIFIED:20220823T135256Z
UID:6579-1665565200-1665594000@carb-x.org
SUMMARY:INTO CLINICAL PRACTICE: MEETING THE CHALLENGES OF GRAM-NEGATIVE INFECTION MANAGEMENT
DESCRIPTION:This virtual conference will explore the current challenges and treatment opportunities for Gram-negative infections. Delegates will\, through plenary lectures and debate\, learn about clinical presentations of Gram-negatives and the latest in research and development. \nDr. Erin Duffy will be a featured presenter during session seven: What Does the Future Look Like? Improving Gram-Negative Treatments.
URL:https://carb-x.org/event/into-clinical-practice-meeting-the-challenges-of-gram-negative-infection-management/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221012T080000
DTEND;TZID=America/New_York:20221012T170000
DTSTAMP:20260404T013146
CREATED:20220916T193234Z
LAST-MODIFIED:20220916T193234Z
UID:6641-1665561600-1665594000@carb-x.org
SUMMARY:AMR: Science\, Society\, Commercialization and Policy
DESCRIPTION:The solution to the AMR problem lies as much with disciplines outside of biomedicine as within it. Thus\, a major goal of the AMR Task Force is to engage and connect those working outside the biomedical sciences\, with those working within it. With strong Business and Engineering schools\, thriving Social Science and Humanities Faculties\, and renowned Science and Health Science Faculties\, we are eager to build on McMaster’s strong history of interdisciplinary collaboration\, and catalyze university-wide AMR research under the auspices of Global Nexus. \nThis one-day symposium aims to promote action within the McMaster community around themes including scientific\, economic and societal issues related to AMR. The day will include a morning symposium where internationally acclaimed thought leaders will speak broadly to these themes\, followed by afternoon workshops focused on brainstorming opportunities and hurdles associated with addressing key issues\, and ideas for future conversations and collaborations. \nSpeakers include Ayush Kumar\, a professor of microbiology at the University of Manitoba; Christine Årdal\, a senior advisor at the Institute of Public Health in Norway; Kevin Outterson\, a professor of law at Boston University and the executive director of CARB-X; and Muhammad H. Zaman\, a professor of biomedical engineering at Boston University.
URL:https://carb-x.org/event/amr-science-society-commercialization-and-policy/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221011T080000
DTEND;TZID=America/New_York:20221014T170000
DTSTAMP:20260404T013146
CREATED:20220722T203715Z
LAST-MODIFIED:20220722T203715Z
UID:6471-1665475200-1665766800@carb-x.org
SUMMARY:World Vaccine Congress | Europe
DESCRIPTION:The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. \nNow in its 23rd year the World Vaccine Congress Europe and co-located events\, Veterinary Vaccine and Immuno-Oncology congresses will continue to bring experts from the whole value chain under one roof. \nInfluenza & Respiratory  •  Emerging & Re-emerging  •  Clinical Trials  •  Bioprocessing & Manufacturing  •  Technology  •  Antimicrobial Resistance  •  Partnerships
URL:https://carb-x.org/event/world-vaccine-congress-europe/
LOCATION:Palau de Congressos de Barcelona
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Africa/Nairobi:20221010T190000
DTEND;TZID=Africa/Nairobi:20221010T203000
DTSTAMP:20260404T013146
CREATED:20220928T202329Z
LAST-MODIFIED:20220928T202329Z
UID:6682-1665428400-1665433800@carb-x.org
SUMMARY:The Broken Pipeline of Antibiotics and Ongoing Efforts to Fix It
DESCRIPTION:This webinar has been prepared in collaboration with CARB-X\, a global non-profit partnership accelerating antibacterial products to address drug-resistant bacteria\, a leading cause of death around the world. \nThe webinar is part of the AMR Ambassadors Program open webinars and aims at educating us about the complex process behind antibiotic/diagnostics research\, development and approval\, challenges associated with it\, and the negative implications. This will help us value the antibiotics already approved for use\, and hopefully encourage us to educate others to appreciate these antibiotics\, and actively take part in their conversation. \nWe will be inspired to support ongoing efforts\, develop creative interventions in our own small ways\, and hopefully trigger the interest of tertiary level students and early career professionals to pursue a further education or a career in drug discovery\, and development. \nDr. Erin Duffy will be the keynote speaker for this webinar.
URL:https://carb-x.org/event/the-broken-pipeline-of-antibiotics-and-ongoing-efforts-to-fix-it/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221004T080000
DTEND;TZID=America/New_York:20221007T170000
DTSTAMP:20260404T013146
CREATED:20220829T160504Z
LAST-MODIFIED:20220929T150049Z
UID:6604-1664870400-1665162000@carb-x.org
SUMMARY:ESCMID/ASM Conference on Drug Development
DESCRIPTION:The 2022 ESCMID/ASM Joint Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance will take place in Dublin\, Ireland on October 4-7\, 2022. Make sure to save the date. \nAntimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID)\, this multidisciplinary meeting will address the challenges\, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance. \nDr. Erin Duffy\, CARB-X Chief of R&D\, will be presenting on preclinical development of non-traditional/novel classes during Symposium 7.
URL:https://carb-x.org/event/escmid-asm-conference-on-drug-development/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220914T153000
DTEND;TZID=America/New_York:20220914T163000
DTSTAMP:20260404T013146
CREATED:20220901T135337Z
LAST-MODIFIED:20220901T135337Z
UID:6611-1663169400-1663173000@carb-x.org
SUMMARY:Center for Pathogen Research & Training Open Webinar ft. Professor Outterson
DESCRIPTION:Professor Kevin Outterson\, J.D.\, LL.M\, Executive Director\, CARB-X will be speaking on the topic of “Repairing the broken business model for antimicrobial R&D” \nWednesday\, September 14\, 2022\, 3:30 p.m.\nZoom ID: 953 7011 3908
URL:https://carb-x.org/event/center-for-pathogen-research-training-open-webinar-ft-professor-outterson/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220907T080000
DTEND;TZID=America/New_York:20220908T170000
DTSTAMP:20260404T013146
CREATED:20220722T203355Z
LAST-MODIFIED:20220722T203355Z
UID:6468-1662537600-1662656400@carb-x.org
SUMMARY:World AMR Congress 2022
DESCRIPTION:Since 2015\, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet\, brainstorm ideas and formulate initiatives that can effectively tackle antimicrobial resistance. \nJoin us for the World AMR Congress and get full access to the Disease Prevention & Control Summit co-located at the Gaylord National Resort & Convention Center on September 7-8.
URL:https://carb-x.org/event/world-amr-congress-2022/
LOCATION:Gaylord National Resort & Convention Center\, National Harbor\, MD\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220828
DTEND;VALUE=DATE:20220901
DTSTAMP:20260404T013146
CREATED:20210621T184527Z
LAST-MODIFIED:20210621T184527Z
UID:5461-1661644800-1661990399@carb-x.org
SUMMARY:The 19th International Symposium on Staphylococci and Staphylococcal Infections
DESCRIPTION:It is a pleasure to invite you to participate in the 19th International Symposium on Staphylococci and Staphylococcal Infections\, which will be held on 28 – 31 August 2022 in Perth\, Australia. \nISSSI 2022 will cover many interdisciplinary subjects regarding staphylococci and staphylococcal infections. Sessions will be presented by the world’s leading experts in each of the research fields. Oral and poster sessions will be an integral part of the program as well\, and all delegates are invited to submit abstracts. To promote discussion and interaction between delegates and the invited speakers\, the meeting’s registration includes the welcome reception\, lunches and morning and afternoon teas. \nISSSI 2022 will be held at the Perth Convention and Exhibition Centre located in the heart of the city. World class public transport\, hotels and internationally acclaimed bars and restaurants are all within walking distance from the Centre. The Perth international and domestic airport terminals are only a short transit to the city and are serviced by numerous daily direct flights from Asia and Europe. \nWe are confident that you will find the symposium’s programme both scientifically stimulating and informative and we look forward to meeting you in Perth. \nClick here to learn more.\nClick here to view the agenda.\nClick here to register.
URL:https://carb-x.org/event/the-19th-international-symposium-on-staphylococci-and-staphylococcal-infections/
LOCATION:Perth Convention and Exhibition Centre (PCEC)\, 21 Mounts Bay Rd\, Perth\, WA\, 6000\, Australia
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220729T080000
DTEND;TZID=America/New_York:20220731T170000
DTSTAMP:20260404T013146
CREATED:20220711T143644Z
LAST-MODIFIED:20220711T143644Z
UID:6416-1659081600-1659286800@carb-x.org
SUMMARY:CFRI’s 35th Virtual National CF Education Conference: Focus on the Future
DESCRIPTION:The Cystic Fibrosis Research Institute is holding its 35th Virtual National CF Education Conference this year from July 29-31\, 2022. The conference\, with a theme of “Focus on the Future\,” brings together the national and international Cystic Fibrosis community for a virtual weekend of content and connection. Nationally-renowned presenters will address subjects that are vital to the CF community.\n\n\n\nHear from CFRI-funded researchers on innovative CF research\, visit pharmaceutical & medical technology exhibits\, and attend support groups and workshops. Socialize with members of the global CF community and honor CF heroes at an inspirational awards ceremony.
URL:https://carb-x.org/event/cfris-35th-virtual-national-cf-education-conference-focus-on-the-future/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220727T120000
DTEND;TZID=America/New_York:20220728T143000
DTSTAMP:20260404T013146
CREATED:20220706T183222Z
LAST-MODIFIED:20220706T183432Z
UID:6366-1658923200-1659018600@carb-x.org
SUMMARY:Workshop on Generation and Measurement of Vaccine Durability
DESCRIPTION:Workshop objectives are to 1) review knowledge about vaccine durability; 2) identify factors contributing to vaccine durability; 3) explore assays and markers to measure vaccine durability in people; and 4) identify gaps in the knowledge about vaccine durability requiring further research or funding. NIAID program staff are organizing this workshop along with external experts in vaccinology and immunology.
URL:https://carb-x.org/event/workshop-on-generation-and-measurement-of-vaccine-durability/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220630T090000
DTEND;TZID=America/New_York:20220630T100000
DTSTAMP:20260404T013146
CREATED:20220627T150035Z
LAST-MODIFIED:20220627T150035Z
UID:6342-1656579600-1656583200@carb-x.org
SUMMARY:A Grand Bargain for Antimicrobial Procurement: Leveraging Purchasing Systems to Address AMR
DESCRIPTION:Join the Center for Global Development for a conversation on new purchasing systems for antimicrobials and the grand bargain stakeholders must strike to govern the global market. This discussion will draw from a new landscape review of antibiotic procurement systems\, which synthesized existing research and thinking on how antimicrobials are procured and ways to improve the current purchasing system. This research was undertaken as part of CGD’s working group\, A Grand Bargain for Antimicrobial Procurement. Speakers will discuss strategies for improving access\, stewardship\, and innovation for antimicrobials; promising new procurement models; and the rights and responsibilities of stakeholders in both LMICs and HICs to facilitate a healthy pipeline of antimicrobials that defends against AMR. \nPresenter\nAnthony McDonnell\, Senior Policy Analyst\, Center for Global Development \nPanelists\nKevin Outterson\, Executive Director\, CARB-X; Professor\, Boston University School of Law\nFatema Rafiqi\, Research Programme Manager for the Antimicrobial Resistance Benchmark\, Access to Medicine Foundation\nRachel Silverman Bonnifield\, Policy Fellow\, Center for Global Development\nMirfin Mpundu\, Director\, ReAct Africa\nModerator \nJavier Guzman\, Director of Global Health Policy and Senior Policy Fellow\, Center for Global Development
URL:https://carb-x.org/event/a-grand-bargain-for-antimicrobial-procurement-leveraging-purchasing-systems-to-address-amr/
LOCATION:VIRTUAL EVENT
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220626
DTEND;VALUE=DATE:20220702
DTSTAMP:20260404T013146
CREATED:20210621T184205Z
LAST-MODIFIED:20210621T184205Z
UID:5460-1656201600-1656719999@carb-x.org
SUMMARY:Gordon Research Conference: Drug Resistance
DESCRIPTION:The chair is currently developing a description for this conference. Please check back for updates. \nClick here to learn more.
URL:https://carb-x.org/event/gordon-research-conference-drug-resistance/
LOCATION:Bryant University\, 1150 Douglas Pike\, Smithfield\, RI\, United States
END:VEVENT
END:VCALENDAR